Xiaoping Peng

Nanchang, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 74 publications

Pulmonary Denervation for Heart Failure-Related Pulmonary Hypertension.

Pulmonary Denervation for Heart Failure-Related Pulmonary Hypertension.

Journal: The New England journal of medicine

Published: August 31, 2026

Angiography-Derived FFR versus IVUS to Guide PCI According to Angiographic Lesion Characteristics.

Angiography-Derived FFR versus IVUS to Guide PCI According to Angiographic Lesion Characteristics.

Journal: Circulation. Cardiovascular interventions

Published: May 19, 2026

STK39 interacts with MAPK14 to facilitate cardiomyocyte pyroptosis in septic cardiomyopathy by inducing NLRP3 inflammasome.

STK39 interacts with MAPK14 to facilitate cardiomyocyte pyroptosis in septic cardiomyopathy by inducing NLRP3 inflammasome.

Journal: Molecular immunology

Published: April 15, 2026

Bivalirudin Versus Heparin in Low and Non-Low Bleeding Risk Patients Undergoing Primary PCI for STEMI: The BRIGHT-4 Trial.

Bivalirudin Versus Heparin in Low and Non-Low Bleeding Risk Patients Undergoing Primary PCI for STEMI: The BRIGHT-4 Trial.

Journal: Journal of the American College of Cardiology

Published: March 03, 2026

Novel Transcatheter Edge-to-Edge Repair System for High-Risk Primary Mitral Regurgitation: 2-Year Pivotal Trial Outcomes.

Novel Transcatheter Edge-to-Edge Repair System for High-Risk Primary Mitral Regurgitation: 2-Year Pivotal Trial Outcomes.

Journal: JACC. Asia

Published: February 24, 2026

Novel Transcatheter Edge-to-Edge Repair System for Degenerative Mitral Regurgitation: 1-Year Outcomes.

Novel Transcatheter Edge-to-Edge Repair System for Degenerative Mitral Regurgitation: 1-Year Outcomes.

Journal: JACC. Asia

Published: February 20, 2026

Canagliflozin Alleviates Pressure Overload-Induced Cardiac Dysfunction via PINK1 Regulation by Inhibiting Mitophagy-Driven Ferroptosis.

Canagliflozin Alleviates Pressure Overload-Induced Cardiac Dysfunction via PINK1 Regulation by Inhibiting Mitophagy-Driven Ferroptosis.

Journal: The Canadian journal of cardiology

Published: January 29, 2026

Targeting DDAH II with Puerarin ameliorates doxorubicin-induced endothelial damage and ferroptosis through ADMA/NOS dysregulation rescue.

Targeting DDAH II with Puerarin ameliorates doxorubicin-induced endothelial damage and ferroptosis through ADMA/NOS dysregulation rescue.

Journal: Journal of advanced research

Published: January 08, 2026

Elevated Circulating HMGB1 Levels as a Potential Biomarker for the Diagnosis and Therapy of Heart Failure: A Cross-Sectional Study.

Elevated Circulating HMGB1 Levels as a Potential Biomarker for the Diagnosis and Therapy of Heart Failure: A Cross-Sectional Study.

Journal: Reviews in cardiovascular medicine

Published: January 05, 2026

Methyltransferase METTL1 Upregulates USF2 in a m7G-Dependent Manner to Accelerate Septic Cardiomyopathy by Inactivating PINK1/Parkin-Mediated Mitophagy.

Methyltransferase METTL1 Upregulates USF2 in a m7G-Dependent Manner to Accelerate Septic Cardiomyopathy by Inactivating PINK1/Parkin-Mediated Mitophagy.

Journal: Cardiovascular toxicology

Published: December 15, 2025

Complement Components C1r and C8 Serve as Potential Inflammatory Biomarkers for Coronary Heart Disease Severity: The Mediating Role of C-Reactive Protein.

Complement Components C1r and C8 Serve as Potential Inflammatory Biomarkers for Coronary Heart Disease Severity: The Mediating Role of C-Reactive Protein.

Journal: Journal of inflammation research

Published: November 26, 2025

Ferroptosis: key regulatory pathways and their implications in cardiovascular pathophysiology.

Ferroptosis: key regulatory pathways and their implications in cardiovascular pathophysiology.

Journal: Frontiers in cardiovascular medicine

Published: October 25, 2025

Showing 1-12 of 74

Last Updated: 09/26/2026